ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum

Rhea-AI Summary

ResMed (NYSE: RMD) announces participation of CEO Mick Farrell in a virtual fireside chat at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum on March 22, 2022, at 1:30 p.m. EDT. The event will be available via webcast, with a replay accessible within an hour after the live session. ResMed focuses on innovative healthcare solutions for chronic diseases, supporting better patient care through digital health technologies and cloud-connected devices, operating in over 140 countries.

Positive

• Participation in a well-regarded investment forum could enhance investor engagement.
• CEO's involvement may boost company visibility within the healthcare investment community.

Negative

• None.

SAN DIEGO, March 17, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum on Tuesday, March 22, 2022, beginning at approximately 1:30 p.m. (Eastern Daylight Time) via webcast.

More information about this event, including access to the live webcast, may be accessed by visiting https://investor.resmed.com. The webcast replay will be available approximately one hour after the live webcast ends and will be accessible through June 20, 2022.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For investors                   
Amy Wakeham                 
+1 858.836.5000
investorrelations@resmed.com

For media
Jayme Rubenstein
+1 858.836.6798
news@resmed.com

FAQ

When is the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum?

The forum is scheduled for March 22, 2022, at 1:30 p.m. EDT.

How can I access the webcast of ResMed's CEO at the investor forum?

Access the live webcast by visiting ResMed's investor relations website.

What is ResMed's primary focus in healthcare?

ResMed specializes in innovative solutions for chronic diseases, including sleep apnea and COPD.

In how many countries does ResMed operate?

ResMed operates in over 140 countries worldwide.